This website uses cookies to enhance your browsing experience, improve site performance, and gather analytics. By selecting 'Accept,' you consent to these cookies as described in our Privacy Policy.

Evaluation of Modified Treatment Regimens for Treatment of Heavy Menstrual Bleeding Using the HerOption® System

Sponsored by CooperSurgical Inc.

About this trial

Last updated 8 years ago

Study ID

AMS043

Status

Completed

Type

Interventional

Phase

Phase 4

Placebo

No

Accepting

18-75 Years
30 to 100 Years
Female
Female

Not accepting

Not accepting
Healthy Volunteers

Trial Timing

Ended 16 years ago

What is this trial about?

The Her Option® Cryoablation Therapy System is a closed-loop cryosurgical device that is used to ablate the endometrial lining in pre-menopausal women with menorrhagia (excessive menstrual bleeding) due to benign causes. This is a non-incisional procedure, which can be performed in a physicians office with minimal sedation. Initial FDA clinical studies were conducted with a two-freeze treatment pattern consisting of a 4 minute freeze with the Cryoprobe positioned in one cornu followed by a second freeze of 6 minutes with the Cryoprobe repositioned in the contralateral cornu. Since completion of the early studies, many physicians have experimented with varying freeze patterns using longer freeze durations and/or additional freezes at the fundus and the lower uterine segment. The results, as reported in the literature, indicate that these extended freeze patterns produce significantly better results than the original regimen.

What are the participation requirements?

Yes

Inclusion Criteria

- Pre-menopausal adult women 30 years of age or older who have completed childbearing

- Heavy or prolonged menstrual bleeding

- Willing and able to complete all follow-up exams as required by protocol

No

Exclusion Criteria

- Known or suspected endometrial cancer or pre-malignant change of the endometrium

- Untreated cervical dysplasia

- Hereditary malformations of the uterine cavity that would prevent insertion and/or placement of the cryoprobe

- Uterine myomas > or = to 3 cm in diameter

- Past history of invasive treatment for abnormal uterine bleeding or uterine myomas

- History of classical (not low transverse incision) cesarean section

- Active genital or urinary tract infection or acute pelvic inflammatory disease (PID)

- Intrauterine device (IUD) in place

- Other medical conditions could be exclusionary upon evaluation for study treatment

Locations

Location

Status